Yale University

The lifetime medical cost savings from preventing HIV in the United States.

TitleThe lifetime medical cost savings from preventing HIV in the United States.
Publication TypeJournal Article
Year of Publication2015
AuthorsSchackman, Bruce R., John A. Fleishman, Amanda E. Su, Bethany K. Berkowitz, Richard D. Moore, Rochelle P. Walensky, Jessica E. Becker, Cindy Voss, David A. Paltiel, Milton C. Weinstein, Kenneth A. Freedberg, Kelly A. Gebo, and Elena Losina
JournalMedical care
Volume53
Issue4
Pagination293-301
Date Published2015 Apr
ISSN1537-1948
KeywordsAdolescent, Adult, Anti-Retroviral Agents, CD4 Lymphocyte Count, Computer Simulation, Cost Savings, Health Care Costs, HIV Infections, Humans, Middle Aged, Models, Economic, United States, Young Adult
AbstractEnhanced HIV prevention interventions, such as preexposure prophylaxis for high-risk individuals, require substantial investments. We sought to estimate the medical cost saved by averting 1 HIV infection in the United States.
DOI10.1097/MLR.0000000000000308
Alternate JournalMed Care

External Links